ArticleJournal of translational medicine2021

A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape.

Peiling Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.